This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kumar, R. Articles by Callen, D. F. Search for Related Content PubMed PubMed Citation Articles by Kumar, R. Articles by Callen, D. F.

---

Signaling and Regulation

ZNF652, A Novel Zinc Finger Protein, Interacts with the Putative Breast Tumor Suppressor CBFA2T3 to Repress Transcription

¹ Breast Cancer Genetics Group, Dame Roma Mitchell Cancer Research Laboratories, Department of Medicine, University of Adelaide and Hanson Institute; ² Endocrine Bone Laboratory, Hanson Institute, Adelaide, South Australia, Australia; ³ Department of Laboratory Genetics, Women's and Children's Hospital, North Adelaide, South Australia, Australia; ⁴ Bionomics, Ltd., Thebarton, South Australia, Australia; and ⁵ Lawrence Berkeley National Laboratory, Berkeley, California

Requests for reprints: David F. Callen, Breast Cancer Genetics Group, Dame Roma Mitchell Cancer Research Laboratories, Hanson Institute, Institute of Medical and Veterinary Science, Frome Road, Adelaide, SA 5000, Australia. Phone: 61-8-8222-23145; Fax: 61-8-8222-3217. E-mail: david.callen{at}imvs.sa.gov.au.

The transcriptional repressor CBFA2T3 is a putative breast tumor suppressor. To define the role of CBFA2T3, we used a segment of this protein as bait in a yeast two-hybrid screen and identified a novel uncharacterized protein, ZNF652. In general, primary tumors and cancer cell lines showed lower expression of ZNF652 than normal tissues. Together with the location of this gene on the long arm of chromosome 17q, a region of frequent loss of heterozygosity in cancer, these results suggest a possible role of ZNF652 in tumorigenesis. In silico analysis of this protein revealed that it contains multiple classic zinc finger domains that are predicted to bind DNA. Coimmunoprecipitation assays showed that ZNF652 strongly interacts with CBFA2T3 and this interaction occurs through the COOH-terminal 109 amino acids of ZNF652. In contrast, there was a weak interaction of ZNF652 with CBFA2T1 and CBFA2T2, the other two members of this ETO family. Transcriptional reporter assays further confirmed the strength and selectivity of the ZNF652-CBFA2T3 interaction. The transcriptional repression of growth factor independent-1 (GFI-1), a previously characterized ETO effector zinc finger protein, was shown to be enhanced by CBFA2T1, but to a lesser extent by CBFA2T2 and CBFA2T3. We therefore suggest that each of the various gene effector zinc finger proteins may specifically interact with one or more of the ETO proteins to generate a defined range of transcriptional repressor complexes. (Mol Cancer Res 2006;4(9):655–65)

This article has been cited by other articles:

				R. Kumar, K. M. Cheney, R. McKirdy, P. M. Neilsen, R. B. Schulz, J. Lee, J. Cohen, G. W. Booker, and D. F. Callen CBFA2T3-ZNF652 Corepressor Complex Regulates Transcription of the E-box Gene HEB J. Biol. Chem., July 4, 2008; 283(27): 19026 - 19038. [Abstract] [Full Text] [PDF]

				Q. Yin, J. McBride, C. Fewell, M. Lacey, X. Wang, Z. Lin, J. Cameron, and E. K. Flemington MicroRNA-155 Is an Epstein-Barr Virus-Induced Gene That Modulates Epstein-Barr Virus-Regulated Gene Expression Pathways J. Virol., June 1, 2008; 82(11): 5295 - 5306. [Abstract] [Full Text] [PDF]

				R Holm, S Knopp, R Kumar, J Lee, J M Nesland, C Trope, and D F Callen Expression of ZNF652, a novel zinc finger protein, in vulvar carcinomas and its relation to prognosis J. Clin. Pathol., January 1, 2008; 61(1): 59 - 63. [Abstract] [Full Text] [PDF]